Proterris and Alfama complete merger to create carbon monoxide therapy leader

Proterris has announced the completion of its merger with Alfama, creating a dominant player in carbon monoxide (CO) therapies.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news